Teva intros generic MoviPrepTeva's generic MoviPrep is available in dosage strengths of 100 g, 7.5 g, 2.691 g, 1.015 g, 5.9 g and 4.7 g. Alembic obtains 2 FDA approvals, 1 tentativeDesonide lotion 0.05% had a market value of $7 million, and empagliflozin and linagliptin tablets, 10 mg/5 mg and 25 mg/5 mg, had a market value of $244 million for the 12 months ended June 2020. Alembic rolls out generic Differin Gel Alembic’s adapalene gel is available in a 45-mg gel tube and a 45-mg gel pump. Dr. Reddy’s launches generic Cuprimine For the year ended June 2020, the Cuprimine brand and generic equivalents had a 12-month market value of $80 million, according to IQVIA data. FDA clears Amneal’s lidocaine patch 5% The product had annual sales of roughly $282 million for the year ended June 2020, according to IQVIA data. Actavis’ Alimta generic approved by FDA The Food and Drug Administration has approved Actavis’ pemetrexed, a generic of the branded chemotherapy treatment Alimta, in three dosage strengths. AAM names president, CEO Dan Leonard joins the Association for Accessible Medicines from the National Pharmaceutical Council, where he was president and CEO. Lupin’s ProAir HFA generic gets FDA green light Of the $2.9 billion in albuterol sulfate sales in the year ended June 2020, ProAir HFA comprised $1.3 billion of that market. Ascend Labs’ generic Jadenu Sprinkle obtains FDA approval Ascend has started shipping its generic Jadenu Sprinkle, which is indicated for patients with iron overload, and announced several staff additions. Camber intros generic Rapaflo Camber's silodosin capsules provide a generic treatment for enlarged prostates. First Previous 149 150 151 152 153 Next Last
